SlideShare a Scribd company logo
CLINICAL TOXICOLOGY ANTIDOTES
PHARM.D Page 1
ANTIDOTES
T.SOUJANYA
PHARM.D
16DC1T0021
CLINICAL TOXICOLOGY ANTIDOTES
PHARM.D Page 2
ANTIDOTES
Definition: According to WHO, an antidote is defined as a therapeutic substance
used to counteract the toxic actions of a specified xenobiotic. Antidotes reduce the
overall burden of health service in managing of poisoning cases.
The term antidote is a Greek word “Antididonai” meaning “given against”. In
Cambridge dictionary, antidote is defined as a chemical especially a drug that limits
the effects of a poison or a way of preventing or acting against something bad.
Poison + antidote = destroy poisoning
Classification of antidote: According to mode of action, they are classified as
follows:
1. Physiological/pharmacological antidote
2. Physical antidote
3. Chemical antidote
1. Physiological/pharmacological antidote: It counteracts the effects of a poison
by producing the opposite pharmacological effects.
e.g.: ACHE inhibitor morphine
Pharmacological antidotes may neutralize or antagonize the effects of a toxicant.
This type of antidote may act by following 5 mechanisms:
• Preventing the formation of toxic metabolites.
• By facilitation of more rapid or complete elimination of a toxicant.
• By competing with the toxicant’s action at a receptor site.
• By blocking receptors responsible for the toxic effect.
• By aiding in the restoration of normal function.
2. Physical antidote: The agent which is used to interfere with poison through
physical properties, not change their nature is known as physical antidote.
CLINICAL TOXICOLOGY ANTIDOTES
PHARM.D Page 3
a) Adsorbing: Adsorption is the adhesion of atoms, ions or molecules from a
gas, liquid or dissolved solid to a surface. This process creates a film of the
adsorbate on the surface of the adsorbent.
e.g.: Activated charcoal (Universal antidote)
b) Coating: A mixture of egg and milk make a coat over the mucosa.
c) Dissolving: 10% alcohol or glycerine for carbolic acid.
3. Chemical antidote: It interacts specifically with a toxicant or neutralize the
toxicant.
e.g.: Metal chelators combine with metals to form complexes that can then be
eliminated by the kidneys.
It mainly act by 2 mechanisms:
i) Complex formation.
ii) Metabolic conversion.
i) Complex formation: antidote make complex with the toxicant making it
unavailable to cross the membrane or to interact with the receptors.
e.g.: DMSA (dimercaprol and dimercaptosuccinic acid are sulfhydryl compounds
that bind metals such as arsenic acid, lead).
ii) Metabolic conversion:
Detoxification to less toxic product: Nitrate interact with haemoglobin and cyanide
to form cyanomethaemoglobin, which is less toxic than cyanide and interfere with
the cyanide access to cytochrome oxidase system.
Nitrite + oxyhaemoglobin methaemoglobin + Cyanide
cyanomethaemoglobin
Antidote administration: Antidotes work in any one of a no. of ways. Common
modes of action are as follows:
1. Inert complex formation.
2. Accelerated detoxification.
3. Reduced toxic conversion.
CLINICAL TOXICOLOGY ANTIDOTES
PHARM.D Page 4
4. Receptor site competition.
5. Receptor site blockage.
6. Toxic effect bypass.
1. Inert complex formation: Some antidotes interact with the poison to form an
inert complex which is then excreted from the body.
e.g.: a) Chelating agents for heavy metals.
b) Prussian blue for thallium.
c) Dicobalt edetate for cyanide etc.
2. Accelerated detoxification: Some antidotes accelerate the detoxification of a
poison.
e.g.: Acetyl cysteine acts as a glutathione substitute which combines with
hepatotoxic paracetamol metabolites and detoxifies them.
Thiosulfate accelerates the conversion of cyanide to nontoxic thiocyanate.
Cyanide thiosulfate thiocyanate (detoxification)
(toxic) (antidote) (nontoxic)
3. Reduced toxic conversion: Antidote reduce the conversion of toxic product.
e.g.: Ethanol which inhibits the metabolism of methanol to toxic metabolites by
competing for the same enzyme (alcohol dehydrogenase).
methanol
alcohol dehydrogenase
formaldehyde
alcohol dehydrogenase
formic acid
folate
Co2 and H2O
CLINICAL TOXICOLOGY ANTIDOTES
PHARM.D Page 5
4. Receptor site competition: Some antidotes displace the poison from specific
receptor sites, thereby antagonizing the effects completely.
e.g.: Naloxone which antagonizes the effects of opioids at stereo-specific opioid
receptor sites.
5. Receptor site blockage: Antidote binds to the receptor site of poison and block
its action.
e.g.: This mode of action is best exemplified by atropine which blocks the effects of
anticholinesterase agents such as organophosphates at muscarinic receptor sites.
6. Toxic effect bypass: Antidote bypasses the toxic effect of poison.
e.g.: 100% oxygen in cyanide poisoning.
CLINICAL TOXICOLOGY ANTIDOTES
PHARM.D Page 6

More Related Content

What's hot

Communication skill for the pharmacist
Communication skill for the pharmacistCommunication skill for the pharmacist
Communication skill for the pharmacist
Merin Babu
 

What's hot (20)

Essential drug concept and rational use of medicines
Essential drug concept and rational use of medicinesEssential drug concept and rational use of medicines
Essential drug concept and rational use of medicines
 
General principles involved in management of poisoning- by rxvichu!!
General principles involved in management of poisoning- by rxvichu!!General principles involved in management of poisoning- by rxvichu!!
General principles involved in management of poisoning- by rxvichu!!
 
POISON & ANTIDOTE
POISON & ANTIDOTEPOISON & ANTIDOTE
POISON & ANTIDOTE
 
Legality of prescription..pptx
Legality of prescription..pptxLegality of prescription..pptx
Legality of prescription..pptx
 
Antidote
AntidoteAntidote
Antidote
 
Patient counselling clinical pharmacy
Patient counselling clinical pharmacyPatient counselling clinical pharmacy
Patient counselling clinical pharmacy
 
Poison information center
Poison information centerPoison information center
Poison information center
 
Elimination enhancement
Elimination enhancementElimination enhancement
Elimination enhancement
 
General principles in treatment of common drug poisoining
General principles in treatment of common drug poisoining General principles in treatment of common drug poisoining
General principles in treatment of common drug poisoining
 
Drug interactions
Drug interactionsDrug interactions
Drug interactions
 
Basic concepts - Pharmacology
Basic concepts - PharmacologyBasic concepts - Pharmacology
Basic concepts - Pharmacology
 
Essential Drug Concept
Essential Drug ConceptEssential Drug Concept
Essential Drug Concept
 
Antidote
AntidoteAntidote
Antidote
 
General principles involved in management of poisoning (Part 1)
General principles involved in management of poisoning (Part 1)General principles involved in management of poisoning (Part 1)
General principles involved in management of poisoning (Part 1)
 
Adverse drug reaction
Adverse   drug  reactionAdverse   drug  reaction
Adverse drug reaction
 
Narcotics and non narcotics analgesics
Narcotics and non narcotics analgesicsNarcotics and non narcotics analgesics
Narcotics and non narcotics analgesics
 
Communication skill for the pharmacist
Communication skill for the pharmacistCommunication skill for the pharmacist
Communication skill for the pharmacist
 
Rational drug use
Rational drug useRational drug use
Rational drug use
 
Introduction to rational use of drugs and role of pharmacist in rational use...
Introduction to  rational use of drugs and role of pharmacist in rational use...Introduction to  rational use of drugs and role of pharmacist in rational use...
Introduction to rational use of drugs and role of pharmacist in rational use...
 
Toxic studies
Toxic studiesToxic studies
Toxic studies
 

Similar to Antidotes

Similar to Antidotes (20)

ppt of antivenom.pptx
ppt of antivenom.pptxppt of antivenom.pptx
ppt of antivenom.pptx
 
Antidotes
AntidotesAntidotes
Antidotes
 
Heavy Metal Poisoning.pdf
Heavy Metal Poisoning.pdfHeavy Metal Poisoning.pdf
Heavy Metal Poisoning.pdf
 
Topical Agents/Topical Medication
Topical Agents/Topical MedicationTopical Agents/Topical Medication
Topical Agents/Topical Medication
 
COMPLEXATION AND PROTEIN BINDING
COMPLEXATION AND PROTEIN BINDINGCOMPLEXATION AND PROTEIN BINDING
COMPLEXATION AND PROTEIN BINDING
 
ANTIDOTE.pptx
ANTIDOTE.pptxANTIDOTE.pptx
ANTIDOTE.pptx
 
Antidotes
AntidotesAntidotes
Antidotes
 
INTRO OF PIC.pptx
INTRO OF PIC.pptxINTRO OF PIC.pptx
INTRO OF PIC.pptx
 
Metabolism
MetabolismMetabolism
Metabolism
 
Xenobiotics
XenobioticsXenobiotics
Xenobiotics
 
Bioransformation ( Biopharmaceutics )
Bioransformation ( Biopharmaceutics )Bioransformation ( Biopharmaceutics )
Bioransformation ( Biopharmaceutics )
 
Xenobiotics Metabolism
Xenobiotics Metabolism Xenobiotics Metabolism
Xenobiotics Metabolism
 
TOXINS
TOXINSTOXINS
TOXINS
 
Catalysis Presentation
Catalysis PresentationCatalysis Presentation
Catalysis Presentation
 
Bioransformation ( Biopharmaceutics )
Bioransformation ( Biopharmaceutics )Bioransformation ( Biopharmaceutics )
Bioransformation ( Biopharmaceutics )
 
GIT.pptx
GIT.pptxGIT.pptx
GIT.pptx
 
Antidotes
AntidotesAntidotes
Antidotes
 
Principles of management in a case of poisoning part 2
Principles of management in a case of poisoning part 2Principles of management in a case of poisoning part 2
Principles of management in a case of poisoning part 2
 
4. drug metabolism
4. drug metabolism4. drug metabolism
4. drug metabolism
 
Complexation
ComplexationComplexation
Complexation
 

More from Soujanya Pharm.D

More from Soujanya Pharm.D (20)

Clinical symptoms and management of Arsenic poisoning
Clinical symptoms and management of Arsenic poisoningClinical symptoms and management of Arsenic poisoning
Clinical symptoms and management of Arsenic poisoning
 
Organophosphate poisoning and its management (Clinical Toxicology)
Organophosphate poisoning and its management (Clinical Toxicology)Organophosphate poisoning and its management (Clinical Toxicology)
Organophosphate poisoning and its management (Clinical Toxicology)
 
Gut decontamination or methods of poison removal in clinical toxicology
Gut decontamination or methods of poison removal in clinical toxicology Gut decontamination or methods of poison removal in clinical toxicology
Gut decontamination or methods of poison removal in clinical toxicology
 
Pathophysiology and management of Malaria
Pathophysiology and management of MalariaPathophysiology and management of Malaria
Pathophysiology and management of Malaria
 
Classification, Pathophysiology and management of Brain Stroke for Pharm.D (P...
Classification, Pathophysiology and management of Brain Stroke for Pharm.D (P...Classification, Pathophysiology and management of Brain Stroke for Pharm.D (P...
Classification, Pathophysiology and management of Brain Stroke for Pharm.D (P...
 
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
Pathophysiology of Parkinsonism and its management for Pharm.D (Pharmacothera...
 
Liver function tests for Pharm.D (Medicinal biochemistry & Clinical pharmacy)
Liver function tests for Pharm.D (Medicinal biochemistry & Clinical pharmacy)Liver function tests for Pharm.D (Medicinal biochemistry & Clinical pharmacy)
Liver function tests for Pharm.D (Medicinal biochemistry & Clinical pharmacy)
 
Types of Anxiety disorders and treatment
Types of Anxiety disorders and treatmentTypes of Anxiety disorders and treatment
Types of Anxiety disorders and treatment
 
Stages of syphilis and its treatment
Stages of syphilis and its treatment Stages of syphilis and its treatment
Stages of syphilis and its treatment
 
Venous thromboembolism for Pharm.D
Venous thromboembolism for Pharm.DVenous thromboembolism for Pharm.D
Venous thromboembolism for Pharm.D
 
Drug induced liver disorders for Pharm.D
Drug induced liver disorders for Pharm.DDrug induced liver disorders for Pharm.D
Drug induced liver disorders for Pharm.D
 
Pain pathways & Pain management for Pharm.D
Pain pathways & Pain management for Pharm.DPain pathways & Pain management for Pharm.D
Pain pathways & Pain management for Pharm.D
 
Pathophysiology and management of alzheimer's disease
Pathophysiology and management of alzheimer's diseasePathophysiology and management of alzheimer's disease
Pathophysiology and management of alzheimer's disease
 
Hypersensitivity reactions
Hypersensitivity reactionsHypersensitivity reactions
Hypersensitivity reactions
 
Pathophysiology and management of epilepsy
Pathophysiology and management of epilepsyPathophysiology and management of epilepsy
Pathophysiology and management of epilepsy
 
Renal dialysis or renal replacement therapy
Renal dialysis or renal replacement therapy Renal dialysis or renal replacement therapy
Renal dialysis or renal replacement therapy
 
HLA system and major histocompatibility complex
HLA system and major histocompatibility complexHLA system and major histocompatibility complex
HLA system and major histocompatibility complex
 
Evidence based medicine
Evidence based medicineEvidence based medicine
Evidence based medicine
 
Pathophysiology and clinical management of gouty arthritis
Pathophysiology and clinical management of gouty arthritisPathophysiology and clinical management of gouty arthritis
Pathophysiology and clinical management of gouty arthritis
 
Pathophysiology and clinical management of tuberculosis
Pathophysiology and clinical management of tuberculosisPathophysiology and clinical management of tuberculosis
Pathophysiology and clinical management of tuberculosis
 

Recently uploaded

Mastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial FreedomMastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial Freedom
FatimaMary4
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 

Recently uploaded (20)

Compare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCompare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from home
 
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptxFinal CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
Final CAPNOCYTOPHAGA INFECTION by Gauri Gawande.pptx
 
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptxCURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx
 
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
Impact of cancers therapies on the loss in cardiac function, myocardial fffic...
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
 
Gauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptxGauri Gawande(9) Constipation Final.pptx
Gauri Gawande(9) Constipation Final.pptx
 
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptxDECIPHERING COMMON ECG FINDINGS IN ED.pptx
DECIPHERING COMMON ECG FINDINGS IN ED.pptx
 
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
1130525--家醫計畫2.0糖尿病照護研討會-社團法人高雄市醫師公會.pdf
 
Retinal consideration in cataract surgery
Retinal consideration in cataract surgeryRetinal consideration in cataract surgery
Retinal consideration in cataract surgery
 
Why invest into infodemic management in health emergencies
Why invest into infodemic management in health emergenciesWhy invest into infodemic management in health emergencies
Why invest into infodemic management in health emergencies
 
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
Non-Invasive assessment of arterial stiffness in advanced heart failure patie...
 
Mastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial FreedomMastering Wealth: A Path to Financial Freedom
Mastering Wealth: A Path to Financial Freedom
 
Contact dermaititis (irritant and allergic).pdf
Contact dermaititis (irritant and allergic).pdfContact dermaititis (irritant and allergic).pdf
Contact dermaititis (irritant and allergic).pdf
 
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
TEST BANK For Wong’s Essentials of Pediatric Nursing, 11th Edition by Marilyn...
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...Relationship between vascular system disfunction, neurofluid flow and Alzheim...
Relationship between vascular system disfunction, neurofluid flow and Alzheim...
 
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t..."Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...
 

Antidotes

  • 1. CLINICAL TOXICOLOGY ANTIDOTES PHARM.D Page 1 ANTIDOTES T.SOUJANYA PHARM.D 16DC1T0021
  • 2. CLINICAL TOXICOLOGY ANTIDOTES PHARM.D Page 2 ANTIDOTES Definition: According to WHO, an antidote is defined as a therapeutic substance used to counteract the toxic actions of a specified xenobiotic. Antidotes reduce the overall burden of health service in managing of poisoning cases. The term antidote is a Greek word “Antididonai” meaning “given against”. In Cambridge dictionary, antidote is defined as a chemical especially a drug that limits the effects of a poison or a way of preventing or acting against something bad. Poison + antidote = destroy poisoning Classification of antidote: According to mode of action, they are classified as follows: 1. Physiological/pharmacological antidote 2. Physical antidote 3. Chemical antidote 1. Physiological/pharmacological antidote: It counteracts the effects of a poison by producing the opposite pharmacological effects. e.g.: ACHE inhibitor morphine Pharmacological antidotes may neutralize or antagonize the effects of a toxicant. This type of antidote may act by following 5 mechanisms: • Preventing the formation of toxic metabolites. • By facilitation of more rapid or complete elimination of a toxicant. • By competing with the toxicant’s action at a receptor site. • By blocking receptors responsible for the toxic effect. • By aiding in the restoration of normal function. 2. Physical antidote: The agent which is used to interfere with poison through physical properties, not change their nature is known as physical antidote.
  • 3. CLINICAL TOXICOLOGY ANTIDOTES PHARM.D Page 3 a) Adsorbing: Adsorption is the adhesion of atoms, ions or molecules from a gas, liquid or dissolved solid to a surface. This process creates a film of the adsorbate on the surface of the adsorbent. e.g.: Activated charcoal (Universal antidote) b) Coating: A mixture of egg and milk make a coat over the mucosa. c) Dissolving: 10% alcohol or glycerine for carbolic acid. 3. Chemical antidote: It interacts specifically with a toxicant or neutralize the toxicant. e.g.: Metal chelators combine with metals to form complexes that can then be eliminated by the kidneys. It mainly act by 2 mechanisms: i) Complex formation. ii) Metabolic conversion. i) Complex formation: antidote make complex with the toxicant making it unavailable to cross the membrane or to interact with the receptors. e.g.: DMSA (dimercaprol and dimercaptosuccinic acid are sulfhydryl compounds that bind metals such as arsenic acid, lead). ii) Metabolic conversion: Detoxification to less toxic product: Nitrate interact with haemoglobin and cyanide to form cyanomethaemoglobin, which is less toxic than cyanide and interfere with the cyanide access to cytochrome oxidase system. Nitrite + oxyhaemoglobin methaemoglobin + Cyanide cyanomethaemoglobin Antidote administration: Antidotes work in any one of a no. of ways. Common modes of action are as follows: 1. Inert complex formation. 2. Accelerated detoxification. 3. Reduced toxic conversion.
  • 4. CLINICAL TOXICOLOGY ANTIDOTES PHARM.D Page 4 4. Receptor site competition. 5. Receptor site blockage. 6. Toxic effect bypass. 1. Inert complex formation: Some antidotes interact with the poison to form an inert complex which is then excreted from the body. e.g.: a) Chelating agents for heavy metals. b) Prussian blue for thallium. c) Dicobalt edetate for cyanide etc. 2. Accelerated detoxification: Some antidotes accelerate the detoxification of a poison. e.g.: Acetyl cysteine acts as a glutathione substitute which combines with hepatotoxic paracetamol metabolites and detoxifies them. Thiosulfate accelerates the conversion of cyanide to nontoxic thiocyanate. Cyanide thiosulfate thiocyanate (detoxification) (toxic) (antidote) (nontoxic) 3. Reduced toxic conversion: Antidote reduce the conversion of toxic product. e.g.: Ethanol which inhibits the metabolism of methanol to toxic metabolites by competing for the same enzyme (alcohol dehydrogenase). methanol alcohol dehydrogenase formaldehyde alcohol dehydrogenase formic acid folate Co2 and H2O
  • 5. CLINICAL TOXICOLOGY ANTIDOTES PHARM.D Page 5 4. Receptor site competition: Some antidotes displace the poison from specific receptor sites, thereby antagonizing the effects completely. e.g.: Naloxone which antagonizes the effects of opioids at stereo-specific opioid receptor sites. 5. Receptor site blockage: Antidote binds to the receptor site of poison and block its action. e.g.: This mode of action is best exemplified by atropine which blocks the effects of anticholinesterase agents such as organophosphates at muscarinic receptor sites. 6. Toxic effect bypass: Antidote bypasses the toxic effect of poison. e.g.: 100% oxygen in cyanide poisoning.